These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9406148)

  • 21. Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
    Baumann G; Ningel K; Permanetter B
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S23-30. PubMed ID: 2478788
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles.
    Holubarsch C; Hasenfuss G; Just H; Blanchard E; Mulieri LA; Alpert NR
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S13-7. PubMed ID: 2478786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low concentrations of UD-CG 212 enhance myocyte contractility by an increase in calcium responsiveness in the presence of inorganic phosphate.
    van Meel JC; Redemann N; Diederen W; Haigh RM
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Jun; 351(6):644-50. PubMed ID: 7675124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potent stimulation of myofilament force and adenosine triphosphatase activity of canine cardiac muscle through a direct enhancement of troponin C Ca++ binding by MCI-154, a novel cardiotonic agent.
    Kitada Y; Kobayashi M; Narimatsu A; Ohizumi Y
    J Pharmacol Exp Ther; 1989 Jul; 250(1):272-7. PubMed ID: 2545860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular effects of UD-CG 212 CL, a metabolite of pimobendan, in anaesthetized pigs.
    Verdouw PD; Levinsky L; Duncker DJ; Rutteman AM; Saxena PR
    Eur J Pharmacol; 1987 Jun; 137(2-3):219-26. PubMed ID: 2886352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pimobendan (UD-CG 115 BS) on left ventricular inotropic state in conscious dogs and in patients with heart failure.
    Pouleur H; Hanet C; Schröder E; Col J; Van Mechelen H; Etienne J; Rousseau MF
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S18-22. PubMed ID: 2478787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute effects of intravenous UD-CG 115 BS (pimobendan) on the cardiovascular system and left ventricular pump function.
    Permanetter B; Sebening H; Hartmann F; Klein G
    J Cardiovasc Pharmacol; 1989; 14 Suppl 2():S36-40. PubMed ID: 2478790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Responsiveness of the myofilaments to Ca2+ in human heart failure: implications for Ca2+ and force regulation.
    Hajjar RJ; Grossman W; Gwathmey JK
    Basic Res Cardiol; 1992; 87 Suppl 1():143-59. PubMed ID: 1497567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maximal Ca2+-activated force and myofilament Ca2+ sensitivity in intact mammalian hearts. Differential effects of inorganic phosphate and hydrogen ions.
    Marban E; Kusuoka H
    J Gen Physiol; 1987 Nov; 90(5):609-23. PubMed ID: 3694173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The novel inotropic agent CGP 48506 alters force primarily by Ca(2+)-independent mechanisms in porcine skinned trabeculae.
    Palmer S; Di Bello S; Davenport SL; Herzig JW
    Cardiovasc Res; 1996 Aug; 32(2):411-21. PubMed ID: 8796129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of sulmazole and pimobendan on contractility of skinned fibres from frog skeletal muscle.
    Piazzesi G; Morano I; Rüegg JC
    Arzneimittelforschung; 1987 Oct; 37(10):1141-3. PubMed ID: 3435586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of new inotropic agents on Ca++ sensitivity of contractile proteins.
    Rüegg JC
    Circulation; 1986 Mar; 73(3 Pt 2):III78-84. PubMed ID: 2935329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of pimobendan and UD-CG-212 CL on calcium exchange and contraction in isolated rabbit aorta.
    Tejerina T; Sesin J; Delgado C; Gonzalez P; Tamargo J
    Arch Int Pharmacodyn Ther; 1990; 305():69-85. PubMed ID: 2241431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CGP-48506 increases contractility of ventricular myocytes and myofilaments by effects on actin-myosin reaction.
    Wolska BM; Kitada Y; Palmiter KA; Westfall MV; Johnson MD; Solaro RJ
    Am J Physiol; 1996 Jan; 270(1 Pt 2):H24-32. PubMed ID: 8769730
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inotropic and lusitropic effects of MCI-154 (6-[4-(4- pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone) on human myocardium.
    Warren SE; Kihara Y; Pesaturo J; Gwathmey JK; Phillips P; Morgan JP
    J Mol Cell Cardiol; 1989 Oct; 21(10):1037-45. PubMed ID: 2555525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
    von Meel JC
    Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transient and sustained changes in myofilament sensitivity to Ca2+ contribute to the inotropic effects of sevoflurane in rat ventricle.
    Graham MD; Bru-Mercier G; Hopkins PM; Harrison SM
    Br J Anaesth; 2005 Mar; 94(3):279-86. PubMed ID: 15608045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MCI-154, a novel cardiotonic agent, reverses the acidic pH-induced decrease in responses of cardiac myofilaments to Ca++: comparison with sulmazole and pimobendan.
    Kitada Y; Abe Y; Narimatsu A; Tobe A
    J Pharmacol Exp Ther; 1991 May; 257(2):812-9. PubMed ID: 2033522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.